Freightcar America Names James Meyer as New CEO

Freightcar America Names James Meyer as New CEO

Freightcar America has named James Meyer as president and CEO, effective July 31. Meyer will succeed Joseph McNeely, who will leave the company by mutual consent to pursue new opportunities. Meyer, 56, joins the company from Commercial Specialty Truck Holdings, LLC, a commercial truck manufacturer, where he has served as chairman of the board and has been an investor and advisor since 2015. From 2012 to 2015, he served as […]

Read More ˃
Six Flags Entertainment Rises

Six Flags Entertainment Rises

Shares of Six Flags Entertainment climbed more than 2% intraday after Stifel analysts were cited as saying the sell-off in the stock this year is overdone. While admitting the company could “modestly underperform” in Q2, analysts Steven Wieczynski and Brad Boyer reiterated their Buy rating on the stock with a $73 price target. The recent declines in the share price could be attributable to poor weather that muted the start […]

Read More ˃
Heartland Express Acquires Interstate Distributor Co.

Heartland Express Acquires Interstate Distributor Co.

Heartland Express has acquired 100% of the outstanding stock of Interstate Distributer Co. of Tacoma, Washington from Saltchuk Resources, Inc., the company said Thursday. The enterprise value of the transaction was approximately $113 million. The transaction was funded through $94 million of Heartland’s existing cash, plus assumption of approximately $23 million of Interstate Distributer’s debt, and acquisition of $4 million in cash on Interstate Distributer’s balance sheet. Heartland expects to […]

Read More ˃
L3 Wins Multi-Year Order

L3 Wins Multi-Year Order

L3 Technologies said pre-market Thursday it has received an initial $89.2 million firm-fixed-price contract award from the U.S. Army. L3 said it will supply M783 Point Detonating/Delay (PD/DLY) Mortar Fuzes and M734A1 Multi-Option Fuze for Mortars (MOFM). This is a multi-year contract with a base award and four option years, which, if fully exercised, has the potential to exceed $230 million. The M783 and M734A1 fuzes are the U.S. Army’s […]

Read More ˃
Novartis Gets European Approval for Kisqali

Novartis Gets European Approval for Kisqali

Novartis AG said Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of Kisqali in combination with an aromatase inhibitor to treat postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer as initial endocrine-based therapy. The CHMP recommendation of combining Kisqali with any aromatase inhibitor means […]

Read More ˃